Drug industry seeks to block Medicare fixes

Democrats in control of Congress hope to give Medicare the authority to negotiate the price of medicines with drugmakers, but are facing problems in changing the law and may need to hold hearings and determine just how to provide the authority before they can proceed. Drugmakers are looking to the Senate and launching campaigns to protect them against such a move, saying price negotiations will lead to price controls and restrictions on access to drugs.

View Full Article in:

Wall Street Journal (free content), The · Los Angeles Times (tiered subscription model) · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY